Vincent Charlon
Directeur Général chez Anergis SA
Profil
Vincent Charlon currently works at Anergis SA, as Chief Executive Officer from 2009 and Tollys, as Chief Executive Officer.
Dr. Charlon also formerly worked at Hesperion AG, as Chief Executive Officer in 2006, LS Pharma International SA, as Chief Executive Officer in 2008, Hoffmann-La Roche, Inc., as Director-Clinical Research, and Roche Holding AG, as Clinical Research Scientist in 1998.
Postes actifs de Vincent Charlon
| Sociétés | Poste | Début |
|---|---|---|
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Directeur Général | 30/03/2011 |
Tollys
 Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon. | Directeur Général | - |
Anciens postes connus de Vincent Charlon
| Sociétés | Poste | Fin |
|---|---|---|
LS Pharma International SA
 LS Pharma International SA Miscellaneous Commercial ServicesCommercial Services LS Pharma International SA provides administrative and accounting assistance services. The private company is based in Geneva, Switzerland. | Directeur Général | 01/01/2008 |
Hesperion AG
 Hesperion AG Miscellaneous Commercial ServicesCommercial Services Hesperion AG provided clinical development services. The firm focused on establishing clinical development partnerships with medical device, biotech and pharmaceutical companies. The company headquartered in Allschwil, Switzerland, | Directeur Général | 01/01/2006 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Directeur Technique/Scientifique/R&D | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/1998 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Hesperion AG
Hesperion AG Miscellaneous Commercial ServicesCommercial Services Hesperion AG provided clinical development services. The firm focused on establishing clinical development partnerships with medical device, biotech and pharmaceutical companies. The company headquartered in Allschwil, Switzerland, | Commercial Services |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Health Technology |
LS Pharma International SA
LS Pharma International SA Miscellaneous Commercial ServicesCommercial Services LS Pharma International SA provides administrative and accounting assistance services. The private company is based in Geneva, Switzerland. | Commercial Services |
Tollys
Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon. | Health Services |